New SPECT/MR holds promise for a variety of clinical uses

06/13/2013 | Diagnostic Imaging

SPECT/MR was introduced at an imaging meeting as a flexible preclinical molecular imaging approach that could deliver improved resolution and lower radiation dose. Possible indications include imaging for cardiovascular and neurological disease, cancer, endocrine disorders and much more. Experts including Benjamin Tsui have developed the technology with TriFoil Imaging, and Tsui said human trials are on the horizon in the next couple of years.

View Full Article in:

Diagnostic Imaging

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL